The administration of ergot or ergot derivatives has been shown to result in a continuous spasm of the muscular coat of peripheral arteries, leading to cyanotic induration, ulceration, and, in many instances, to gangrene of the tissues.1' 25,7 In 1935, McGrath reported4 that female albino rats could be protected from the more severe manifestations of ergotamine intoxication by the daily injection of ovarian follicular hormone (Theelin). He found that male rats similarly treated with Theelin were not protected, although the onset of ulceration and gangrene was delayed. In view of the greater incdence of peripheral vascular disease in men as compared with women, these experimental findings attracted considerable interest. Further reports on the use of ovarian hormone therapy in experimental ergotamine intoxication were published in 1938 by Loewe and Lenke8 and by Suzmann, Freed, and Prag.' Employing the methods used by McGrath, Loewe and Lenke were unable to produce gangrene in the tails of all their rats by a single injection. They found, however, that divided doses given over a three-day period did result in the development of gangrene in 100 per cent of their animals. They then tested the effects of Theelin and of Progynon-B (Schering), as well as the effects of castration of male rats, on the course of ergotamine intoxication. With daily doses of from 2 to 10 rat units of Theelin per day, as recommended by McGrath, no changes were noted; the amount was raised to 30 rat units and finally to 500 rat units per day of Progynon-B without effect.
On the other hand Suzmann, Freed, and Prag, using similar methods, reported that repeated daily doses of 500 I. U. of cestroform afforded female rats complete protection from gangrene of the tail, while male rats were only slightly affected. It must be noted that while no definite quantitative relationship-can be deter-mined between "rat units" and International Units, a rat unit is considered from 3 to 12 times as effective as an International Unit. Thus, the dosage used by Loewe and Lenke, and found to be ineffective, exceeded that used by Suzmann and his colleagues. These discrepances led to repetition of the experiments both with ergotamine alone and with sex hormones.
Materials and methods White rats weighing 150 gm. were used. They were placed on a standard ration of fox chow, oats, and greens, and observed for several days prior to the beginning of the experiment. They were all in good health and active. The ergot preparation used was ergotamine tartrate (Gynergen, Sandoz) and was dissolved in distilled water made slightly acid with tartaric acid. Theelin (aqueous solution) was used as a source of ovarian hormone.
Two groups of ten male and two groups of ten female rats were injected subcutaneously with 5 mg. of ergotamine tartrate. One group of female rats and one group of male rats were subsequently injected with 20 I.U. of Theelin per day for a period of 28 days. The other groups served as controls. All rats were examined daily, and drawings were made of any unusual appearances of the tails.
Results
Four rats died within 24 hours following the injection of ergotamine. The others were acutely ill and showed loss of appetite and diminished activity for the first 24 hours, but returned to normal in appearance and behavior by 36 to 48 hours. During the following 20 days 7 of the rats receiving Theelin exhibited a marked cyanosis of the tail and 3 of these developed gangrene. In the control group 7 showed cyanosis and of these, 4 developed gangrene. In both groups the females showed as much change as did the males, in some instances a greater change. There was no uniformity in the rate at which these changes occurred; some rats developed gangrene within 5 days after the injection, and one rat had sloughed several centimeters of tail within 36 hours. Others exhibited only cyanosis after 15 or 20 days. Among these there were no differences referable to sex. No further changes were noted after 20 days.
From the results of this experiment it was evident that the amount of ergotamine required to produce vascular changes was sufficient to endanger the life of the animal. In an attempt to increase the incidence of vascular change a second experiment was carried out in which ergotamine was injected repeatedly; an initial dose of 7 mg. was followed in 19 days by a second dose of 3.5 mg., 10 days later by a dose of 5 mg., and 29 days later, or 54 days after the first injection, by a final dose of 5 mg. Thirty rats were used, and were divided into the following groups: 10 females which were treated with 20 I. U. of Theelin per day; 10 males treated with 0.5 mg. of testosterone propionate dissolved in peanut-oil; 5 female and 5 male rats, untreated, served as controls.
These injections of sex hormones were commenced five days prior to the first injection of ergotamine and were continued for 93 days. The results of sex hormone therapy were equivocal. As in the first experiment, the control rats and the treated rats developed vascular changes in the same proportion. There was no indication that the repeated injection of ergotamine was more effective than a single dose. Approximately one fourth of the animals died within 24 hours after an injection of ergotamine, but there was no orderliness in this phenomenon; some rats succumbed to the first injection, some to the third or fourth. A few rats developed gangrene after the first injection, while a small number showed no change until the third or fourth injection. Those rats which had developed gangrene early were seemingly unaffected by later injections of ergotamine. All in all there was very little evidence-that the vascular changes induced by ergotamine are in any way constant. A group of S rats injected with ergotamine daily for 3 days according to the method of Loewe and Lenke expired within a few hours after the last injection.
All of the animals were autopsied and histological sections were prepared from the parenchymatous organs, the aorta, and the tail. No findings referable to the experimental procedures were observed in any of the internal organs or in the blood vessels of the trunk. The tails were removed and sections prepared from the distal and proximal portions; usually four separate blocks were chosen, from the base to the tip of the tail or to the most distal healthy tissue. Changes of various types were observed in the central arteries and in the arterioles, almost all of which involved a proliferation of the intimal tissue. Many arterioles in the distal portion of the tails were found to be ocduded by overgrowth of the intimal layer; the central arteries showed similar changes ranging from eccentric proliferations to complete occlusion of the lumen. It was of interest that in those rats which failed to show clinical alterations in the tail or showed only slight congestion or cyanosis, no histological changes were found; while in those rats which showed gangrene it was not uncommon to find extensive changes in the central artery even at the root of the tail many centimeters proximal to the line of demarcation between healthy and involved tissue. In none of the vessels which showed intimal change was there any evidence of thrombus formation, except in the portion which was obviously gangrenous. In addition to the changes noted in the vessels there was evidence that the prolonged cyanosis and induration were accompanied by a diffuse proliferation of the connective tissue elements of the subcutaneous tissue and around the blood vessels.
Conclusions
The administration of either male or female sex hormones to albino rats had no effect on the incidence of gangrene of the tail induced by -ergotamine tartrate. The severity of the changes induced by ergotamine was likewise not altered by hormone therapy.
